New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
08:36 EDTMRK, SSNLF, BIIBMerck, Samsung Bioepis enter collaboration agreement
Merck (MRK) and Samsung Bioepis, a joint venture between Samsung (SSNLF) Biologics and Biogen (BIIB), announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon. Under the terms of the agreement, the companies will collaborate on clinical development, regulatory filings and manufacturing. If approved, Merck will commercialize this candidate. This collaboration builds on the agreement made by the two companies in February 2013 to develop and commercialize multiple biosimilar candidates.
News For MRK;SSNLF;BIIB From The Last 14 Days
Check below for free stories on MRK;SSNLF;BIIB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 25, 2014
16:13 EDTMRKOn The Fly: Closing Wrap
Stocks began the session in positive territory and proceeded to tack on gains throughout the morning. Despite a disappointing report on new home sales in July, the S&P surpassed the 2,000 level for the first time before noon. The market pared its gains shortly after the milestone was reached and drifted for the remainder of the session on light volume, as trading activity may be restrained all week ahead of the Labor Day weekend. ECONOMIC EVENTS: In the U.S., the Chicago Fed's National Activity index jumped to 0.39 in July from an upwardly revised 0.21 in June. Markit's preliminary August services PMI came in at 58.5, which was down from a prior reading of 60.8 but above the 58.0 consensus projection. New home sales dropped 2.4% to a 412K rate in July, missing expectations for them to have risen to a 430K annualized rate. COMPANY NEWS: Shares of InterMune (ITMN) surged $19.05, or 35.41%, to $72.85 after the company agreed to be acquired by Roche (RHHBY) for $74.00 per share in an all-cash transaction. The deal announcement comes less than two weeks after Bloomberg reported that Roche, along with big pharma peers Sanofi (SNY) and GlaxoSmithKline (GSK), had made takeover bids for the smaller drugmaker. A number of other biotech companies gained following the deal announcement, including bigger names like Gilead (GILD) and Celgene (CELG) and smaller ones such as Achillion Pharmaceuticals (ACHN) and Receptos (RCPT)... Burger King (BKW) shares rose $5.29, or 19.51%, to $32.40 after the company confirmed it is in talks regarding a potential strategic transaction with Canadian donut chain Tim Hortons (THI). Shares of Tim Horton's trading in New York also gained $11.88, or 18.91%, to $74.72 following the confirmation of news first reported by The Wall Street Journal. MAJOR MOVERS: Among the other notable gainers was Advaxis (ADXS), which advanced 75c, or 23.08%, to $4.00 after announcing it has entered into a clinical trial collaboration agreement with Merck (MRK). Also rising were shares of Comtech (CMTL), which jumped $1.70, or 4.84%, to $36.81 after Reuters said the company is working with Citigroup to explore a potential sale. Among the noteworthy losers was Chinese internet and software company Qihoo 360 Technology (QIHU), which fell $7.88, or 7.74%, to $93.87 despite reporting second quarter earnings and revenue that beat analysts' estimates. Also lower were shares of GrubHub (GRUB), which fell $3.60, or 8.42%, to $39.16 after filing to sell 10M shares of common stock. INDEXES: The Dow gained 75.65, or 0.44%, to 17,076.87, the Nasdaq rose 18.80, or 0.41%, to 4,557.35, and the S&P 500 advanced 9.54, or 0.48%, to 1,997.94.
09:11 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
07:46 EDTSSNLFSamsung acquisitions underscore smart home ambitions, FT says
Subscribe for More Information
05:17 EDTMRKAdvaxis, Merck enter clinical trial collaboration agreement
Subscribe for More Information
August 22, 2014
12:39 EDTBIIBThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
06:14 EDTSSNLFSamsung resumes supply of mobile RAM for next-generation iPhone, DigiTimes says
Subscribe for More Information
05:07 EDTSSNLFParkerVision names Samsung as additional defendant in patent infringement suit
Subscribe for More Information
August 21, 2014
06:58 EDTSSNLFLarge-size panel demand increases in Q2 with LG Display in lead, DigiTimes says
Subscribe for More Information
06:12 EDTSSNLFDRAM prices making downward correction with oversupply concerns, DigiTimes says
Subscribe for More Information
August 20, 2014
09:32 EDTSSNLFSamsung, Barnes & Noble announce new Samsung Galaxy Tab 4 NOOK
Subscribe for More Information
August 19, 2014
15:48 EDTSSNLFCNET to hold a live blog
CNET holds a live blog of the unveiling of Samsung and Barnes & Noble's Nook tablet in New York on August 20 at 9:30 am. Webcast Link
06:22 EDTSSNLFSamsung acquires Quietside to boost 'smart home' business, Reuters says
Samsung announced that it purchased air conditioner firm Quietside in an effort to boost its "smart home" division, according to Reuters, citing a statement from the company. Samsung said, "Because air conditioning products are a necessity in all buildings, including homes and offices, this acquisition is expected to be of help to our future smart home business." Reference Link
August 18, 2014
09:16 EDTSSNLFSamsung mulls manufacturing smartphones in Jakarta, WSJ says
Samsung is contemplating whether or not to manufacture smartphones at its Jakarta, Indonesia facility, according to The Wall Street Journal, citing comments from a company spokeswoman in an e-mailed statement. Reference Link
07:57 EDTMRKCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
06:03 EDTSSNLFAUO continues to see curved TV orders from Sony and Samsung, DigiTimes says
Subscribe for More Information
August 15, 2014
18:35 EDTBIIBBiogen PLEGRIDY approved in U.S. for treatment of multiple sclerosis
Biogen Idec announced that the FDA has approved PLEGRIDY, a new treatment for people with relapsing forms of multiple sclerosis, or RMS. PLEGRIDY is dosed once every two weeks and can be administered subcutaneously with the PLEGRIDY PEN, a new, ready-to-use autoinjector, or a prefilled syringe. The FDA approval of PLEGRIDY is based on results from one of the largest pivotal studies of beta interferon conducted, ADVANCE, which involved more than 1,500 MS patients.
10:09 EDTSSNLFSony expected to debut Smartwatch 3 next month, GigaOM reports
Subscribe for More Information
07:01 EDTBIIBIsis Pharmaceuticals earns $2M from advancement of ISIS-SMN from Biogen
Isis Pharmaceuticals (ISIS) announced that it has earned a $2M milestone payment from Biogen (BIIB) related to the advancement of the ongoing open-label extension study of ISIS-SMNRx in children with spinal muscular atrophy.
06:02 EDTSSNLFSamsung acquires home automation startup SmartThings, terms not disclosed
SmartThings announced on its blog that it has been acquired by Samsung and will operate as an independent company within Samsung’s Open Innovation Center group. "It has always been our goal to create a totally open smart home platform that brings together third-party developers, device makers, and consumers. We’re thrilled that Samsung fully supports this vision.We will continue to run SmartThings the way we always have: by embracing our community of customers, developers, and device makers and championing the creation of the leading open platform for the smart home. Our growing team will remain fully intact and will relocate to a new headquarters in Palo Alto, CA. In short: SmartThings will remain SmartThings." Reference Link
August 14, 2014
06:19 EDTSSNLFLenovo sees opportunities outside of China for smartphone business, WSJ reports
Lenovo CEO Yang Yuanqing tells the Wall Street Journal that although that China is still the most important market for its smartphone business, the company sees additional opportunities outside China. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use